Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2006; 12(41): 6678-6682
Published online Nov 7, 2006. doi: 10.3748/wjg.v12.i41.6678
Table 1 Characteristics and outcomes of patients ( mean ± SD)
Arterial steroid injection therapy
YesNoTotalP
n171734
Sex (male/female)11/610/721/130.7242
Age (yr)45.1 ± 16.944.8 ± 19.045.0 ± 17.70.9623
Ascites (none/present)12/57/1019/150.0842
Encephalopathy5/4/3/511/0/5/116/4/8/60.0242
(0/1/2/3)
T.bilirubin (mg/dL)9.04 ± 9.2114.48 ± 9.6211.76 ± 9.670.1014
D.bilirubin (mg/dL)6.15 ± 6.739.08 ± 6.717.61 ± 6.790.2131
D/T bilirubin ratio0.66 ± 0.060.61 ± 0.120.64 ± 0.100.1785
Albumin (g/dL)3.55 ± 0.463.25 ± 0.323.40 ± 0.420.0362
ChE (mg/dL)111.7 ± 40.595.4 ± 31.3103.8 ± 36.70.2047
AST (U/L)5817.5 ± 4223.63203.71 ± 2829.24510.62 ± 3780.20.0530
ALT (U/L)4056.7 ± 2427.33643.71 ± 2677.13850.21 ± 2525.00.6407
AST/ALT ratio1.58 ± 1.160.99 ± 0.681.28 ± 0.980.0833
ALP (U/L)539.5 ± 258.3517.8 ± 178.0528.6 ± 218.10.7775
γ-GTP (U/L)336.4 ± 351.2182.0 ± 182.0261.5 ± 288.70.1228
LDH (U/L)4349.3 ± 4479.01343.3 ± 2553.12846.3 ± 3900.60.0238
PT-INR2.50 ± 1.602.93 ± 1.922.71 ± 1.760.4890
Platelet (× 104/μL)13.9 ± 5.511.8 ± 4.212.8 ± 4.90.2121
AFP (ng/mL)16.7 ± 27.229.6 ± 43.823.2 ± 36.50.3125
NH3 (μg/dL)90.5 ± 87.063.6 ± 32.277.1 ± 66.10.2451
BUN (mg/dL)14.1 ± 10.914.8 ± 18.614.4 ± 15.00.8850
Creatinine (mg/dl)1.20 ± 1.301.16 ± 1.241.18 ± 1.250.9210
Outcome13/2/24/7/617/9/80.0085
(Survival/death/LT)
Table 2 Univariate logistic analysis for survival probability
VariablesEstimatePLower 95%Upper 95%Odds ratio
Age (50 vs ≤ 50 yr)-0.60610.0912-0.08021.34153.3608
Sex (male vs female)0.12470.7244-0.57080.83221.2833
Ascites (none vs present)1.20790.00360.44652.103011.1997
Encephalopathy (none vs present)01.0000-0.67990.67991
T.Bil (< 8 mg/dL vs ≥ 8)0.47450.4930-0.87671.86271.6071
D/T. Bil ratio (> 0.65 vs ≤ 0.65)0.48840.4870-0.88251.90221.6296
Albumin (> 3.3 vs ≤ 3.3 g/dL)1.48160.04400.08653.00294.4000
ChE (> 100 vs ≤ 100 mg/dL)0.85740.2306-0.52442.30922.3571
AST (> 3500 vs ≤ 3500 U/L)0.47450.4930-0.87671.86271.6071
ALT (> 4000 vs ≤ 4000 U/L)0.96280.1735-0.39932.40252.6190
AST/ALT ratio (> 1 vs ≤ 1)0.23560.7317-1.11511.60421.2656
LDH (> 600 vs ≤ 600 U/L)1.21220.0912-0.16032.68313.3608
PT-INR (> 2 vs ≤ 2)1.48160.04400.08653.002920.1446
Platelet (>12 × 104/μL vs ≤ 12 × 104)1.75090.02000.33353.31975.7600
AFP (< 5 vs ≥ 5 ng/mL)0.23560.7317-1.11511.46161.2656
NH3 (< 55 vs ≥ 55 μg/mL)0.23560.7317-1.11511.60421.2656
BUN (< 10 vs ≥ 10 mg/dL)0.23560.7317-1.11511.60421.2656
Etiology
HBV (vs HAV)0.32690.5761-0.81961.54051.9230
Others (vs HAV)0.14460.7567-0.77631.07441.3354
TASIT (yes vs no)1.17870.00360.43112.038710.5624
Table 3 Multivariate logistic regression analysis using stepwise variable selection
VariablesEstimatePLower 95%Upper 95%Odds ratio
TASIT (done)1.65350.00760.62203.231227.3009
Platelet (< 12 × 104/μL)2.68710.02610.64505.780514.6895
PT-INR (< 1.0)1.87110.0687-0.01194.15056.4953